BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 26687935)

  • 1. A selective D3 receptor antagonist YQA14 attenuates methamphetamine-induced behavioral sensitization and conditioned place preference in mice.
    Sun L; Song R; Chen Y; Yang RF; Wu N; Su RB; Li J
    Acta Pharmacol Sin; 2016 Feb; 37(2):157-65. PubMed ID: 26687935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel dopamine D3 receptor antagonist YQA14 inhibits methamphetamine self-administration and relapse to drug-seeking behaviour in rats.
    Chen Y; Song R; Yang RF; Wu N; Li J
    Eur J Pharmacol; 2014 Nov; 743():126-32. PubMed ID: 25261038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective dopamine D3 receptor antagonist YQA14 inhibits morphine-induced behavioral sensitization in wild type, but not in dopamine D3 receptor knockout mice.
    Lv Y; Hu RR; Jing M; Zhao TY; Wu N; Song R; Li J; Hu G
    Acta Pharmacol Sin; 2019 May; 40(5):583-588. PubMed ID: 30224637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade of D3 receptors by YQA14 inhibits cocaine's rewarding effects and relapse to drug-seeking behavior in rats.
    Song R; Bi GH; Zhang HY; Yang RF; Gardner EL; Li J; Xi ZX
    Neuropharmacology; 2014 Feb; 77():398-405. PubMed ID: 24176392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repeated restraint stress reduces the acquisition and relapse of methamphetamine-conditioned place preference but not behavioral sensitization.
    Seo JY; Ko YH; Ma SX; Lee BR; Lee SY; Jang CG
    Brain Res Bull; 2018 May; 139():99-104. PubMed ID: 29421246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The dopamine D(3) receptor antagonist YQA14 that inhibits the expression and drug-prime reactivation of morphine-induced conditioned place preference in rats.
    Hu R; Song R; Yang R; Su R; Li J
    Eur J Pharmacol; 2013 Nov; 720(1-3):212-7. PubMed ID: 24436985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of protein phosphatase 2A inhibitor LB100 on regulating methamphetamine induced conditioned place preference in mice.
    Qian H; Wang J; Shang Q; Xiao J; Chen G; Gao B; Liang M; Li T; Liu X
    Neurosci Lett; 2020 Mar; 721():134817. PubMed ID: 32032748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. YQA14: a novel dopamine D3 receptor antagonist that inhibits cocaine self-administration in rats and mice, but not in D3 receptor-knockout mice.
    Song R; Yang RF; Wu N; Su RB; Li J; Peng XQ; Li X; Gaál J; Xi ZX; Gardner EL
    Addict Biol; 2012 Mar; 17(2):259-73. PubMed ID: 21507153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roles of levo-tetrahydropalmatine in modulating methamphetamine reward behavior.
    Su HL; Zhu J; Chen YJ; Zhao N; Han W; Dang YH; Xu M; Chen T
    Physiol Behav; 2013 Jun; 118():195-200. PubMed ID: 23711566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sodium butyrate modulates a methamphetamine-induced conditioned place preference.
    Zhu J; Zhao N; Chen Y; Zhu L; Zhong Q; Liu J; Chen T
    J Neurosci Res; 2017 Apr; 95(4):1044-1052. PubMed ID: 27426635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Valproate blocks high-dose methamphetamine-induced behavioral cross-sensitization to locomotion-inducing effect of dizocilpine (MK-801), but not methamphetamine.
    Ito K; Abekawa T; Koyama T
    Psychopharmacology (Berl); 2006 Jul; 186(4):525-33. PubMed ID: 16758239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methamphetamine-induced locomotor activity and behavioral sensitization: are dopamine d3 receptors involved?
    Jones CD; Bartee JA; Leite-Browning ML; Blackshear MA
    Cell Mol Biol (Noisy-le-grand); 2007 May; 53(4):15-22. PubMed ID: 17531156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of CCL7 and CCL2 in reward system mediated through dopamine D1 receptor signaling underlies methamphetamine-induced place preference in mice.
    Saika F; Kiguchi N; Wakida N; Kobayashi D; Fukazawa Y; Matsuzaki S; Kishioka S
    Neurosci Lett; 2018 Feb; 665():33-37. PubMed ID: 29174638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential Roles of Intra-accumbal Orexin Receptors in Acquisition and Expression of Methamphetamine-Induced Conditioned Place Preference in the Rats.
    Khosrowabadi E; Karimi-Haghighi S; Jamali S; Haghparast A
    Neurochem Res; 2020 Sep; 45(9):2230-2241. PubMed ID: 32643036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The selective dopamine D3 receptor antagonists SB-277011A and NGB 2904 and the putative partial D3 receptor agonist BP-897 attenuate methamphetamine-enhanced brain stimulation reward in rats.
    Spiller K; Xi ZX; Peng XQ; Newman AH; Ashby CR; Heidbreder C; Gaál J; Gardner EL
    Psychopharmacology (Berl); 2008 Mar; 196(4):533-42. PubMed ID: 17985117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Naltrexone attenuates methamphetamine-induced behavioral sensitization and conditioned place preference in mice.
    Wang ZY; Guo LK; Han X; Song R; Dong GM; Ma CM; Wu N; Li J
    Behav Brain Res; 2021 Feb; 399():112971. PubMed ID: 33075396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blockade of the Dopamine D
    Hu RR; Yang MD; Ding XY; Wu N; Li J; Song R
    Neurosci Bull; 2023 Nov; 39(11):1655-1668. PubMed ID: 37040055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of metabotropic glutamate receptor 5 in the inhibition of methamphetamine-associated contextual memory after prolonged extinction training.
    Huang CH; Yu YJ; Chang CH; Gean PW
    J Neurochem; 2016 Apr; 137(2):216-25. PubMed ID: 26748780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of dopamine D3 receptor and dopamine transporter in methamphetamine-induced behavioral sensitization in tree shrews.
    Huang J; Yang G; Li Z; Leung CK; Wang W; Li Y; Liu L; Shen B; He C; He Y; Zeng X; Li J
    Brain Behav; 2020 Feb; 10(2):e01533. PubMed ID: 31943832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cocaine-induced conditioned place preference in mice: induction, extinction and reinstatement by related psychostimulants.
    Itzhak Y; Martin JL
    Neuropsychopharmacology; 2002 Jan; 26(1):130-4. PubMed ID: 11751040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.